Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
LY163892, a new orally administered 1-carbacephem, was found to have a spectrum of antimicrobial activity very similar to that of cefaclor. Diffusion tests with 30-micrograms LY163892 disks produced acceptable interpretive error rates with greater than or equal to 22 mm as the susceptibility zone di...
Guardat en:
| Publicat a: | J Clin Microbiol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1988
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC266445/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3259247/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.26.4.770-773.1988 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|